Ishita Drugs & Indus P/E Ratio
Current P/E Ratio
26.26
High Valuation
High - Growth expectations or overvalued
Ishita Drugs & Indus (ISHITADR) P/E ratio is 26.26 (High), EPS (TTM) ₹2.90, current price ₹77.00 on BSE — High - Growth expectations or overvalued. Analyse ISHITADR promoter holding to track promoter, FII and institutional holdings.
Current Valuation Metrics
P/E Ratio
26.26
Current Price
₹77.00
EPS (TTM)
₹2.90
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
50.01
Sector Median
29.4
Sector Rank
#11 of 190
Sector Percentile
5.8%
ISHITADR P/E Ratio — Valuation Signal & Historical Context
Ishita Drugs & Indus P/E 26.26 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see ISHITADR stock price BSE.
- Stock appears overvalued with PE of 26.26, suggesting caution for new investments
- Trading at discount to sector average PE of 50.01
ISHITADR vs Healthcare Peers — P/E Ratio Comparison
Ishita Drugs & Indus P/E 26.26 vs Healthcare average 50.01, median 29.4 — range 1.0–869.57.
Sector Average
50.01
Sector Median
29.4
Lowest P/E
1.0
Highest P/E
869.57
Companies
190
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.0 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.45 | ₹61 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.69 | ₹1,161 | Low |
| Amwill Health Care | AMWILL | 6.34 | ₹65 | Low |
| Brooks Laboratories | BROOKS | 6.6 | ₹137 | Low |
| Mono Pharmacare | MONOPHARMA | 7.1 | ₹21 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |
| Medicamen Organics | MEDIORG | 7.51 | ₹32 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹66 | Low |